Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1948 1
1949 1
1950 1
1951 1
1952 1
1963 1
1965 1
1972 2
1973 1
1983 1
1986 2
1987 9
1988 6
1989 8
1990 4
1991 8
1992 8
1993 13
1994 15
1995 20
1996 11
1997 10
1998 10
1999 7
2000 17
2001 10
2002 7
2003 20
2004 16
2005 19
2006 20
2007 22
2008 33
2009 36
2010 25
2011 17
2012 31
2013 42
2014 40
2015 36
2016 39
2017 34
2018 32
2019 26
2020 24
2021 21
2022 20
2023 17
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

676 results

Results by year

Filters applied: . Clear all
Page 1
Editorial.
Klijn K, Lees K. Klijn K, et al. Among authors: lees k. Eur Stroke J. 2022 Jun;7(2):91. doi: 10.1177/23969873221097149. Epub 2022 May 24. Eur Stroke J. 2022. PMID: 35647319 Free PMC article. No abstract available.
Editorial.
Klijn K, Lees K. Klijn K, et al. Among authors: lees k. Eur Stroke J. 2022 Dec;7(4):348. doi: 10.1177/23969873221127564. Epub 2022 Dec 2. Eur Stroke J. 2022. PMID: 36478750 Free PMC article. No abstract available.
Editorial.
Lees K, Sandset EC. Lees K, et al. Eur Stroke J. 2023 Dec;8(4):841. doi: 10.1177/23969873231209865. Eur Stroke J. 2023. PMID: 37997382 Free PMC article. No abstract available.
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group. Emberson J, et al. Among authors: lees kr. Lancet. 2014 Nov 29;384(9958):1929-35. doi: 10.1016/S0140-6736(14)60584-5. Epub 2014 Aug 5. Lancet. 2014. PMID: 25106063 Free PMC article. Review.
Editorial.
Lees K, Sandset EC. Lees K, et al. Eur Stroke J. 2024 Jun;9(2):282. doi: 10.1177/23969873241252063. Eur Stroke J. 2024. PMID: 38775252 Free PMC article. No abstract available.
Editorial.
Sandset EC, Lees K. Sandset EC, et al. Among authors: lees k. Eur Stroke J. 2024 Mar;9(1):4. doi: 10.1177/23969873241230490. Eur Stroke J. 2024. PMID: 38439673 Free PMC article. No abstract available.
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators. Hacke W, et al. Among authors: lees kr. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656. N Engl J Med. 2008. PMID: 18815396 Free article. Clinical Trial.
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, Dawson J, Gandhi D, Ullman N, Mould WA, Mayo SW, Mendelow AD, Gregson B, Butcher K, Vespa P, Wright DW, Kase CS, Carhuapoma JR, Keyl PM, Diener-West M, Muschelli J, Betz JF, Thompson CB, Sugar EA, Yenokyan G, Janis S, John S, Harnof S, Lopez GA, Aldrich EF, Harrigan MR, Ansari S, Jallo J, Caron JL, LeDoux D, Adeoye O, Zuccarello M, Adams HP Jr, Rosenblum M, Thompson RE, Awad IA; CLEAR III Investigators. Hanley DF, et al. Among authors: lees kr. Lancet. 2017 Feb 11;389(10069):603-611. doi: 10.1016/S0140-6736(16)32410-2. Epub 2017 Jan 10. Lancet. 2017. PMID: 28081952 Free PMC article. Clinical Trial.
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo SW, Bistran-Hall AJ, Gandhi D, Mould WA, Ullman N, Ali H, Carhuapoma JR, Kase CS, Lees KR, Dawson J, Wilson A, Betz JF, Sugar EA, Hao Y, Avadhani R, Caron JL, Harrigan MR, Carlson AP, Bulters D, LeDoux D, Huang J, Cobb C, Gupta G, Kitagawa R, Chicoine MR, Patel H, Dodd R, Camarata PJ, Wolfe S, Stadnik A, Money PL, Mitchell P, Sarabia R, Harnof S, Barzo P, Unterberg A, Teitelbaum JS, Wang W, Anderson CS, Mendelow AD, Gregson B, Janis S, Vespa P, Ziai W, Zuccarello M, Awad IA; MISTIE III Investigators. Hanley DF, et al. Among authors: lees kr. Lancet. 2019 Mar 9;393(10175):1021-1032. doi: 10.1016/S0140-6736(19)30195-3. Epub 2019 Feb 7. Lancet. 2019. PMID: 30739747 Free PMC article. Clinical Trial.
Editorial.
Sandset EC, Lees K. Sandset EC, et al. Among authors: lees k. Eur Stroke J. 2023 Sep;8(3):609. doi: 10.1177/23969873231189566. Eur Stroke J. 2023. PMID: 37641547 Free PMC article. No abstract available.
676 results